The Evidence Beyond the 2-Year Honeymoon Part 1: The Long-Term Studies That Aren't Being Promoted SUSTAIN-6 (Semaglutide - Ozempic/Wegovy) Duration: 2 years (still short-term in metabolic terms) Findings: 26% reduction in cardiovascular events (great!), but... Buried Data: 47% higher retinopathy complications in diabetes patients Mechanism: Rapid glucose lowering can worsen existing retinopathy via vascular changes LEADER (Liraglutide - Saxenda) Duration: 3.8 years (better, b

The Clinical Miracle & The Metabolic Disaster Part 1: How They Work - The Brilliant Trick (There are some good bio hacks, and some bad ones, here is a very good example of the latter!) GLP-1 (Glucagon-like peptide-1) is a natural hormone released from your gut after eating. It signals: "I'm full" to your brain (satiety) "Release insulin" to your pancreas (lower blood sugar) "Slow down digestion" to your stomach (delayed gastric emptying) GLP-1 agonists (Ozempic, Mounjaro, Weg

The Core Problem Generic exercise and diet plans treat metabolism as a dumb fixed machine that responds predictably to standardized inputs. But we've redefined metabolism as an intelligent, context-sensitive allocation system. This makes generic plans not just suboptimal—they're often metabolically counterproductive. Part 1: How Generic Plans Violate Metabolic Principles 1. They Ignore Individual Energy Allocation Hierarchies Generic Plan Logic: "Do this workout, eat these ma